Suppl Figure 3 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

MLA

Gregory M. Lanza, et al. Suppl Figure 3 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22480220.

APA

Gregory M. Lanza, John F. DiPersio, Ravi Vij, Steven Fletcher, Kathleen Simons, Michael Rettig, Julie Ritchey, Anne H. Schmieder-Atteberry, Julie O’Neal, Mark A. Fiala, Noriko Yanaba, Dipanjan Pan, Grace Cui, Xiaoxia Yang, John S. Allen, Michael J. Scott, & Francesca Fontana. (2023). Suppl Figure 3 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival. https://doi.org/10.1158/1078-0432.22480220

Chicago

Gregory M. Lanza, John F. DiPersio, Ravi Vij, Steven Fletcher, Kathleen Simons, Michael Rettig, Julie Ritchey, et al. 2023. “Suppl Figure 3 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival,” March. doi:10.1158/1078-0432.22480220.